Predict your next investment

Metabolon company logo
Corporation
HEALTHCARE | Biotechnology
metabolon.com

See what CB Insights has to offer

Founded Year

2000

Stage

Debt - II | Alive

Total Raised

$183M

Last Raised

$50.23M | 1 yr ago

About Metabolon

Metabolon is a health technology company focused on metabolomics – a tool for precision medicine and life sciences research. The company's platforms and informatics deliver biomarker discoveries, diagnostic tests, and partnerships in genomics-based, health initiatives.

Metabolon Headquarter Location

617 Davis Dr Suite 100

Morrisville, North Carolina, 27560,

United States

+1 919 572 1711

Latest Metabolon News

‘Demystifies’ the gut: RTP biotech Metabolon unveils new metabolome platform

Nov 27, 2021

RESEARCH TRIANGLE PARK – Metabolon , a Research Triangle Park precision medicine company, has unveiled a new platform and tool to help visualize the metabolome. The metabolome refers to the complete set of small-molecule chemicals found within a biological sample. Metabolon’s Microbiome SmartPanel, the company said, “demystifies” the gut microbiome by zeroing in on biologically relevant microbial and host-derived metabolites, along with xenobiotic molecules, to reveal “deep insight” into microbiome function and its impact on host health. Meanwhile, its proprietary Heliogram visualization tool allows users to explore 13 microbiome pathways for rapid connectivity to the impact of therapeutic interventions on the host microbiome. Metabolon’s Microbiome SmartPanel. — Metabolon photo “Metabolomics is an untapped, under-appreciated biological resource,” said Rangaprasad (Ranga) Sarangarajan, Ph.D., Metabolon’s chief scientific officer. “It can significantly contribute to the evolution of healthcare system technologies because the insights revealed influence almost every aspect of health, treatment of diseases, and health outcomes.” Founded in 2000, Metabolon specializes in a technology called metabolomics, which is the large-scale study of small molecules, commonly known as metabolites, within cells, biofluids, tissues or organisms. The company said it plans to unveil additional SmartPanel offerings in the coming months. In addition, the company is developing novel methods for a number of targeted assays, which can be validated up to Good Clinical Practice (GCP) requirements if needed. “This is the beginning of a robust portfolio of new dynamic and easy-to-understand metabolomics solutions,” said Rohan Hastie, Ph.D., Metabolon’s president and CEO. “Our belief is that by making metabolomics solutions more accessible for use by the broader market, we can make it possible for more drug developers to leverage the power of metabolomics to develop new therapies to improve patient care.” In September 2020, Metabolon wrapped up a new round of fundraising with $72 million in debt and equity. Investors in the $72 million round include Perceptive Advisors, EW Healthcare Partners and other previous investors. (C) N.C. Biotech Center

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Metabolon

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Metabolon is included in 3 Expert Collections, including Omics.

O

Omics

1,303 items

M

Medical Devices

7,884 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Metabolon Patents

Metabolon has filed 65 patents.

The 3 most popular patent topics include:

  • Mass spectrometry
  • Rare diseases
  • Analytical chemistry
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/26/2017

11/23/2021

Mass spectrometry, Analytical chemistry, Ion source, Proteomics, Spectroscopy

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/26/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

11/23/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Mass spectrometry, Analytical chemistry, Ion source, Proteomics, Spectroscopy

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Metabolon Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Metabolon Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.